Zymeworks (ZYME)
(Delayed Data from NSDQ)
$16.25 USD
-0.24 (-1.46%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $16.24 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Zymeworks Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ZYME 16.25 -0.24(-1.46%)
Will ZYME be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ZYME based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZYME
Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus
Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus
ZYME: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates
Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains?
Other News for ZYME
ZYME forms 180 Bullish Setup on September 18
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Zymeworks (ZYME)
Shooting Star Candlestick appears for ZYME after 0.19% move
Upper Bollinger Band Walk appears for ZYME after 0.56% move
ZYME forms Slingshot Bullish on September 15